Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multimodal HOCl-responsive MEH-PPV nanoparticles for anti-inflammatory imaging and therapy

  • Villar-Alvarez, Eva|||0000-0003-4023-1375
  • Parron-Onate, Sara
  • Wienskowska, Olga
  • Carrascull-Marín, Aleix
  • Bellacanzone, Christian|||0000-0002-1986-6440
  • Lorenzo Rivera, Julia|||0000-0001-5659-6008
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
  • Roscini, Claudio|||0000-0002-0157-8934
Inflammatory disorders often correlate with an unusually high intracellular production of hypochlorous acid (HOCl). Therefore, its rapid, sensitive, and specific detection is crucial for an early diagnosis and treatment evaluation. While nanoparticles for detection have already been reported, multimodal nanoparticles that simultaneously detect and eliminate reactive oxygen species (including the excess of HOCl) are scarce despite their interest. Herein, we developed highly selective fluorescent nanoparticles using the copolymer poly(2-methoxy-5-(2-ethylhexyloxy)-1, 4-phenylenevinylene) (MEH-PPV), with (MEH@CS) and without a chitosan coating (MEH). The conjugated polymer is oxidized in the presence of HOCl, exhibiting a rapid (in less than 30 s) and sensitive fluorescence turn-off response with a log-log linear HOCl relationship within dynamic ranges of ≈ 0.784-83 μM and ≈ 0.384-55 μM for MEH and MEH@CS NPs, respectively, allowing to monitor basal HOCl levels within the standard physiological concentration range (5 - 25 μM) and its differentiation from overproduction. Moreover, the nanoparticles can encapsulate and release quercetin (a powerful natural scavenger for HOCl), leading not only to monitoring but also to a reduction in pro-inflammatory cytokines of inflammation-stimulated macrophage cells.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in Glioblastoma

  • Jiménez, Rafael|||0000-0003-4103-8219
  • Constantinescu, Andrada
  • Yazir, Muhube
  • Alfonso Triguero, Paula|||0000-0002-6554-5656
  • Pequerul Pavón, Raquel|||0000-0002-0008-975X
  • Parés i Casasampera, Xavier|||0000-0002-5071-9465
  • Pérez-Alea, Mileidys|||0000-0002-8739-8087
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Farrés, Jaume|||0000-0001-9069-3987
  • Lorenzo Rivera, Julia|||0000-0001-5659-6008
Glioblastoma (GB) is an aggressive malignant central nervous system tumor that is currently incurable. One of the main pitfalls of GB treatment is resistance to the chemotherapeutic standard of care, temozolomide (TMZ). The role of aldehyde dehydrogenases (ALDHs) in the glioma stem cell (GSC) subpopulation has been related to chemoresistance. ALDHs take part in processes such as cell proliferation, differentiation, invasiveness or metastasis and have been studied as pharmacological targets in cancer treatment. In the present work, three novel α,β-acetylenic amino thiolester compounds, with demonstrated efficacy as ALDH inhibitors, were tested in vitro on a panel of six human GB cell lines and one murine GB cell line. Firstly, the expression of the ALDH1A isoforms was assessed, and then inhibitors were tested for their cytotoxicity and their ability to inhibit cellular ALDH activity. Drug combination assays with TMZ were performed, as well as an assessment of the cell death mechanism and generation of ROS. A knockout of several ALDH genes was carried out in one of the human GB cell lines, allowing us to discuss their role in cell proliferation, migration capacity and resistance to treatment. Our results strongly suggest that ALDH inhibitors could be an interesting approach in the treatment of GB, with EC50 values in the order of micromolar, decreasing ALDH activity in GB cell lines to 40-50%.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fluorescent substrates enable specific detection and structure-function insights into human aldehyde dehydrogenase isoforms

  • Pequerul Pavón, Raquel|||0000-0002-0008-975X
  • Covaleda Cortés, Daniela|||0009-0007-4919-0377
  • Sánchez-Vaca, Andrés S.|||0000-0002-7722-7161
  • Torres, Laura
  • Constantinescu, Andrada
  • Pérez-Alea, Mileidys|||0000-0002-8739-8087
  • Parés i Casasampera, Xavier|||0000-0002-5071-9465
  • Farrés, Jaume|||0000-0001-9069-3987
Aldehyde dehydrogenase (ALDH) isoforms are widely used as biomarkers and potential drug targets in cancer research. Quantitation of ALDH enzymatic activity in biological samples often relies on the use of commercially available assays that are quite unspecific and do not discriminate between the various ALDH isoforms. The availability of highly purified recombinant ALDH isoforms allowed us to perform a full kinetic characterization of ALDH isoforms with fluorogenic substrates, BODIPY™-aminoacetaldehyde (BAAA), the ALDEFLUOR™ assay reagent, and two naphthaldedyde derivatives, 6-methoxy-2-naphthaldehyde (MONAL-62) and 7-methoxy-1-naphthaldehyde (MONAL-71). All ALDH1A isoforms were active to different extend with BAAA, while ALDH3A1 did not show any activity. Remarkable kinetic differences between ALDH1A1, ALDH1A2, ALDH1A3, ALDH2 and ALDH3A1 were observed with naphthaldehyde derivatives. Exquisite sensitivity was attained with MONAL-62 with a lower detection limit of 2 amol or 10 molecules of enzyme per microliter for ALDH1A1. The high substrate specificity of ALDH1A1 for MONAL-71 provides an alternative assay for the unambiguous identification of this isoform. Enzymatic properties of isoforms were accounted for by in silico simulations of substrate docking to the active site of ALDH structures. In addition to substrate specificity, inhibitor selectivity of each isoform, as assessed by incubation with DIMATE and ABD0171 inhibitors, provided additional information about isoform composition in low-activity samples isolated from cell extracts. The method was successfully applied to the detection of ALDH isoform activity in triple-negative breast cancer cells.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Resorufin-derived esters as fluorescent probes to test for the esterase activity and active-site topology of aldehyde dehydrogenase

  • Pequerul Pavón, Raquel|||0000-0002-0008-975X
  • Covaleda Cortés, Daniela|||0009-0007-4919-0377
  • Sánchez-Vaca, Andrés S.|||0000-0002-7722-7161
  • Benali, Tarik
  • Ceylan, Ismail|||0000-0002-7491-9269
  • Martin, Guillaume
  • Fournet, Guy
  • Pérez-Alea, Mileidys|||0000-0002-8739-8087
  • Parés i Casasampera, Xavier|||0000-0002-5071-9465
  • Farrés, Jaume|||0000-0001-9069-3987
Aldehyde dehydrogenase (ALDH) isoforms are crucial for cellular detoxification and metabolic regulation, yet their enzymatic properties with non-canonical substrates remain underexplored. ALDH1A isoforms are overexpressed in several cancer types and contribute to tumor aggressiveness and chemoresistance. In this study, we characterize the esterase activity of ALDH1A isoforms using novel resorufin-derived fluorogenic substrates. Steady-state kinetic analysis reveals distinct catalytic efficiencies (k /K ) among isoforms, emphasizing differences in substrate hydrolysis rates and binding affinities. Structural modeling and fluorescence-based assays indicate that NAD binding induces conformational rearrangements that modulate esterase activity. Resorufin-derived esters clearly outperformed 4-nitrophenyl acetate and standard aldehyde substrates of ALDH. These findings provide mechanistic insights into ALDH1A isoform selectivity and expand the application of resorufin-based probes for ALDH functional assays. Our study establishes a foundation for developing targeted ALDH assays and potential applications in cancer drug screening and biomarker discovery.